Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Investigation of the Dose Range of Remimazolam Besylate in Different Age Groups of Adults and Its Effects on Hemodynamics

NCT06009991 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06009991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06009991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Investigation of the Dose Range of Remimazolam Besylate in Different Age Groups of Adults and Its Effects on Hemodynamics
Lead sponsor
Tongji Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 17, 2023
Completion date
December 31, 2025
Enrollment
1,876 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, remimazolam